PROTON MR SPECTROSCOPY OF PEDIATRIC CEREBELLAR TUMORS

被引:0
|
作者
WANG, ZY
SUTTON, LN
CNAAN, A
HASELGROVE, JC
RORKE, LB
ZHAO, HQ
BILANIUK, LT
ZIMMERMAN, RA
机构
[1] CHILDRENS HOSP PHILADELPHIA,DEPT RADIOL,MRI UNIT,PHILADELPHIA,PA 19104
[2] CHILDRENS HOSP PHILADELPHIA,DEPT NEUROSURG,PHILADELPHIA,PA 19104
[3] CHILDRENS HOSP PHILADELPHIA,DEPT BIOSTAT & EPIDEMIOL,PHILADELPHIA,PA 19104
[4] CHILDRENS HOSP PHILADELPHIA,DEPT PATHOL,PHILADELPHIA,PA 19104
关键词
MAGNETIC RESONANCE; SPECTROSCOPY; CEREBELLUM; NEOPLASMS; CHILDREN;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PURPOSE: To investigate the role of proton MR spectroscopy in pediatric cerebellar tumor diagnosis. METHODS: Single voxel pulse sequences with long echo time (135 or 270 milliseconds, voxel size 8 to 19 cm(3)), were used to obtain proton spectra of primary pediatric cerebellar tumors. Eleven primitive neuroectodermal tumors (patient age, 2 to 12 years; mean, 7 years), 11 low-grade astrocytomas (age, 2 to 16 years; mean, 9 years), 4 ependymomas (age, 1 to 6 years; mean, 4 years), 1 mixed glioma ependymo-astrocytoma (age, 11 years), 1 anaplastic ependymoma (age, 7 years), 1 ganglioglioma (age, 14 years), and 1 malignant teratoma (age, 6 days) were studied. Control cerebellum spectra were acquired from five patients without abnormality in cerebellum (age, 2 to 15 years; mean, 8 years). The signal intensities from choline-containing compounds (Cho), creatine/phosphocreatine (Cr), N-acetyl-aspartate (NAA), and lactate (Lac) were quantified. The mean and standard deviation of metabolite ratios were calculated. RESULTS: The control spectra ratios (NAA:Cho = 1.49 +/- 0.36, Cr:Cho = 1.13 +/- 0.23) were distinct from the tumor spectra (NAA:Cho = 0.41 +/- 0.27 and Cr:Cho = 0.37 +/- 0.23). Most of primitive neuroectodermal tumors had low NAA:Cho (0.17 +/- 0.09) and Cr:Cho (0.32 +/- 0.19). Compared with primitive neuroectodermal tumors, low-grade astrocytomas and ependymomas had higher NAA:Cho ratio (0.63 +/- 0.19 and 0.39 +/- 0.12). The Cr:Cho ratio was higher for ependymomas (0.60 +/- 0.20) than For astrocytomas (0.27 +/- 0.12) and primitive neuroectodermal tumors. No NAA was found in the malignant teratoma. Lac:Cho ratio was 0.66 +/- 0.40, 0.58 +/- 0.30, and 0.08 +/- 0.12 for astrocytoma, ependymoma, and primitive neuroectodermal tumor, respectively. Lactate was elevated in the mixed glioma ependymo-astrocytoma, ganglioglioma, and teratoma. The NAA and lactate signals were sometimes obscured by lipids in the spectra. Discriminant analysis was carried out using NAA:Cho and Cr:Cho ratios to differentiate the three major tumor types. The sensitivity/specificity values for diagnosing astrocytoma, ependymoma, and primitive neuroectodermal tumor were found to be 0.91/0.84, 0.75/0.92, and 0.82/0.89, respectively, based on this study. CONCLUSION: in many cases, proton MR spectroscopy can be used to help differentiate cerebellar primitive neuroectodermal tumor, low-grade astrocytoma, and ependymoma.
引用
下载
收藏
页码:1821 / 1833
页数:13
相关论文
共 50 条
  • [1] Proton MR spectroscopy of pediatric brain tumors
    Taylor, JS
    Ogg, RJ
    Langston, JW
    NEUROIMAGING CLINICS OF NORTH AMERICA, 1998, 8 (04) : 753 - +
  • [2] Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia
    Wilkinson, ID
    Hadjivassiliou, M
    Dickson, JM
    Wallis, L
    Grünewald, RA
    Coley, SC
    Widjaja, E
    Griffiths, PD
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (07): : 1011 - 1013
  • [3] Proton MR spectroscopy of common brain tumors
    Castillo, M
    Kwock, L
    NEUROIMAGING CLINICS OF NORTH AMERICA, 1998, 8 (04) : 733 - +
  • [4] Proton MR Spectroscopy of Pediatric Brain Disorders
    Bluml, Stefan
    Saunders, Alexander
    Tamrazi, Benita
    DIAGNOSTICS, 2022, 12 (06)
  • [5] Cerebellar metabolite alterations detected in vivo by proton MR spectroscopy
    Macrì, MA
    Garreffa, G
    Giove, F
    Ambrosini, A
    Guardati, M
    Pierelli, F
    Schoenen, J
    Colonnese, C
    Maraviglia, B
    MAGNETIC RESONANCE IMAGING, 2003, 21 (10) : 1201 - 1206
  • [6] Proton spectroscopy of suprasellar tumors in pediatric patients
    Sutton, LN
    Wang, ZYJ
    Wehrli, SL
    Marwaha, S
    Molloy, P
    Phillips, PC
    Zimmerman, RA
    NEUROSURGERY, 1997, 41 (02) : 388 - 394
  • [7] Perfusion MR imaging and proton MR spectroscopy of neoplasic brain tumors
    Cruz, LH
    Brandao, LA
    Martins, G
    Domingues, RC
    Provenzale, JM
    Domingues, RC
    RADIOLOGY, 2001, 221 : 134 - 134
  • [8] Molecular characterization of musculoskeletal tumors by proton MR spectroscopy
    Fayad, Laura M.
    Barker, Peter B.
    Bluemke, David A.
    SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2007, 11 (03) : 240 - 245
  • [9] Salivary gland tumors at in vivo proton MR spectroscopy
    King, AD
    Yeung, DKW
    Ahuja, AT
    Tse, GMK
    Yuen, HY
    Wong, KT
    van Hasselt, AC
    RADIOLOGY, 2005, 237 (02) : 563 - 569
  • [10] Proton MR spectroscopy of pediatric brain metabolic disorders
    Wang, ZYJ
    Zimmerman, RA
    NEUROIMAGING CLINICS OF NORTH AMERICA, 1998, 8 (04) : 781 - +